Reviewing Jushi (OTCMKTS:JUSHF) and PacificHealth Laboratories (OTCMKTS:PHLI)

PacificHealth Laboratories (OTCMKTS:PHLI) and Jushi (OTCMKTS:JUSHF) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation.

Insider & Institutional Ownership

21.7% of Jushi shares are owned by institutional investors. 38.0% of PacificHealth Laboratories shares are owned by company insiders. Comparatively, 21.7% of Jushi shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Risk & Volatility

PacificHealth Laboratories has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Comparatively, Jushi has a beta of -0.86, indicating that its stock price is 186% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and price targets for PacificHealth Laboratories and Jushi, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PacificHealth Laboratories	0	0	0	0	0.00
Jushi	0	1	0	0	2.00

Given PacificHealth Laboratories’ higher probable upside, research analysts plainly believe PacificHealth Laboratories is more favorable than Jushi.

Earnings & Valuation

This table compares PacificHealth Laboratories and Jushi”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PacificHealth Laboratories	N/A	N/A	N/A	N/A	N/A
Jushi	$269.45 million	0.26	-$65.10 million	($0.27)	-1.31

PacificHealth Laboratories has higher earnings, but lower revenue than Jushi.

Profitability

This table compares PacificHealth Laboratories and Jushi’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PacificHealth Laboratories	N/A	N/A	N/A
Jushi	-20.93%	-5,529.11%	-10.36%

Summary

PacificHealth Laboratories beats Jushi on 6 of the 9 factors compared between the two stocks.

About PacificHealth Laboratories

PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. It primarily focuses on sports performance, hydration, fueling, and muscle recovery. The company provides ENDUROX R4, a muscle recovery drink; ACCELERADE protein powered sports drink; ACCEL GEL, a energy gel; Body Glove Surge; ENDUROX EXCEL, an exercise supplement; and 2ND SURGE, an ultra energy gel. It also offers ACCELERADE HYDRO for less intense workouts use before, during, and after workouts for hydration, energy, and recovery. The company markets its products to various distribution channels, including sports specialty and natural product retailers and chains, as well as markets their products through its Website. PacificHealth Laboratories, Inc. was founded in 1995 and is based in Matawan, New Jersey.

About Jushi

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. It is also involved in the bulk wholesale of refined cannabinoids and terpenes. In addition, the company operates medical cannabis dispensaries under the BEYOND/HELLO, Nature’s Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. The company is headquartered in Boca Raton, Florida.